Angelini Pharma has a total of 194 patents globally, out of which 169 have been granted. Of these 194 patents, 86.08% patents are active. Europe (EPO) is where Angelini Pharma has filed the maximum number of patents, followed by United Kingdom and Japan. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Angelini Pharma.
Founded in 1919, Angelini Pharma is an international pharmaceutical company focused on developing and commercializing innovative medicines that improve patients’ quality of life. The company specializes in brain health, including treatments for epilepsy and mental health disorders, while also maintaining a strong consumer healthcare portfolio. Through its expertise in research, development, manufacturing, and commercialization, Angelini Pharma works to address unmet medical needs and deliver high-quality therapies that improve patient outcomes worldwide.
In July 2026, Angelini Pharma announced the acquisition of Catalyst Pharmaceuticals, significantly expanding its global pharmaceutical portfolio and strengthening its position in the neuroscience market. The acquisition adds Catalyst’s portfolio of therapies for rare neurological and neuromuscular disorders, complementing Angelini Pharma’s expertise in brain health. This strategic move reinforces the company’s commitment to expanding patient access to innovative therapies and advancing its leadership in neuroscience.
Do read about some of the most notable patents of Angelini Pharma covered in this article. You can also explore Angelini Pharma’ patent portfolio, worldwide patent filing activity, patent filing trends over the years, and many other statistics related to its patent portfolio.
How many patents does Angelini Pharma have?
Angelini Pharma has a total of 194 patents globally. These patents belong to 27 unique patent families. Out of 194 patents, 167 patents are active.
How Many Patents did Angelini Pharma File Every Year?
| Year of Patents Filing or Grant | Angelini Pharma Applications Filed | Angelini Pharma Patents Granted |
| 2025 | – | 5 |
| 2023 | – | 1 |
| 2021 | – | 10 |
| 2020 | – | 5 |
| 2019 | – | 8 |
| 2018 | 37 | 33 |
| 2017 | – | 12 |
| 2016 | 11 | 10 |
| 2015 | 1 | 8 |
| 2014 | 12 | 6 |
How many Angelini Pharma patents are Alive/Dead?
Worldwide Patents
How Many Patents did Angelini Pharma File in Different Countries?
Top Countries in which Angelini Pharma Filed Patents
| Country | Patent |
| Europe (EPO) | 30 |
| United Kingdom | 28 |
| Japan | 13 |
| Brazil | 12 |
| Israel | 9 |
| Germany | 9 |
| Russia | 9 |
| United States of America | 8 |
| Italy | 8 |
| Australia | 7 |
| Colombia | 7 |
| Hungary | 6 |
| Spain | 6 |
| Turkey | 6 |
| China | 6 |
| South Africa | 5 |
| Philippines | 5 |
| Hong Kong (S.A.R.) | 2 |
| Poland | 2 |
| Austria | 2 |
| Portugal | 2 |
| Denmark | 1 |
| Slovakia | 1 |
| Switzerland | 1 |
| Thailand | 1 |
| Norway | 1 |
| Korea (South) | 1 |
| Indonesia | 1 |
| Chile | 1 |
| Singapore | 1 |
Track Every Patent Move in Real Time Across 70+ Jurisdictions with Elixir
Where are Research Centres of Angelini Pharma Patents Located?
10 Best Angelini Pharma Patents
US8414919B2 is the most popular patent in the Angelini Pharma portfolio. It has received 16 citations so far from companies like Companies, Sonia Gervais and Alkermes Pharma Ireland Limited.
Below is the list of 10 most cited patents of Angelini Pharma:
| Publication Number | Citation Count |
| US8414919B2 | 16 |
| US20110015205A1 | 9 |
| US7829120B2 | 9 |
| WO2013173703A1 | 7 |
| JP1444377S | 6 |
| RU2497487C2 | 5 |
| RU2399642C2 | 5 |
| US8795723B2 | 4 |
| US9439866B2 | 2 |
| JP1440910S | 2 |
What Percentage of Angelini Pharma US Patent Applications Were Granted?
Angelini Pharma (Excluding its subsidiaries) has filed 9 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 6 have been granted leading to a grant rate of 66.67%
Below are the key stats of Angelini Pharma patent prosecution at the USPTO.
Which Law Firms are managing US Patents for Angelini Pharma?
| Law Firm | Total Applications | Success Rate |
| Goodwin Procter Llp | 8 | 62.5% |
| Fisherbroyles Llp | 1 | 100.0% |
What are Angelini Pharma key innovation segments?
What Technologies are Covered by Angelini Pharma?
The chart below distributes patents filed by Angelini Pharma